Big relief that guidance has been reaffirmed. I hope the new board and management can deliver on their strategy. Glad I got back in 2 days ago!
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress